Navigation Links
Frost & Sullivan Reveals Strategies on Turning Challenges into Opportunities in the European Biomarkers Market

LONDON, Nov. 16 /PRNewswire/ -- The "omics" revolution of the last decade has ensured that the field of biomarker research will test the frontiers of biomedical research in the coming years. New biomarkers are discovered each day and this rapid development promises excellent growth potential for the biomarker analysis market. However, due to various challenges faced in biomarker validation and assay development, there is a huge lag between the time that a biomarker is discovered in the laboratory and the time it is actually commercialized.


In an upcoming Analyst Briefing, Frost & Sullivan will therefore focus on the potential of the European Biomarker Analysis Market. The briefing will be held on Tuesday, 24th November 2009, at 3 p.m. GMT. Highlights of the briefing include an analysis of current trends, challenges, drivers and restraints, significant market developments, a survey of market opportunities and what lies ahead in this vibrant field.

"All stakeholders in the biomarker industry need to come together to circumvent the bottlenecks in this field," says Frost & Sullivan Senior Research Analyst Rasika Ramachandran. "Although the task of bringing together the entire industry for this cause is a formidable one, it seems to be the only solution to the challenge of making biomarker testing reach every drug discovery lab. The long term benefits of such an undertaking should aid in justifying the efforts that are involved in making it happen."

The discussion on the European Biomarker Analysis market will be beneficial to biomarker companies, pharmaceutical manufacturers, biotechnology companies, drug discovery firms and contract research organizations.

To participate in this webinar, please email Patrick Cairns at with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you.

About Frost & Sullivan:

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit

    Patrick Cairns
    Corporate Communications
    P: +27 18 464 2402

SOURCE Frost & Sullivan

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low-Dose Contraceptive Patch
2. Frost & Sullivans 2009 Excellence in Healthcare Awards Banquet Honours Industrys Top Performers
3. Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award
4. Emergence of Newer Drug Classes to Treat Diabetes and Co-morbidities Key to Market Expansion, Reveals Frost & Sullivan
5. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
6. Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
7. Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities
8. SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination
9. Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan
10. Frost & Sullivan Recognizes Cisbio Bioassays for Technology Innovation
11. Frost & Sullivan: Lower Import Duties and Rising Customer Demand to Boost Russian Electronics Manufacturing Market
Post Your Comments:
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/25/2015)... 2015 --> ... - 2020 report analyzes that automating biobanking workflow ... in long-term samples, minimizing manual errors, improving the ... manual errors such as mislabeling or inaccurate sample ... plays a vital role in blood fractionation, DNA ...
(Date:11/25/2015)... , November 25, 2015 ... cat and human plaque and pave the way for more ... problems in cats     --> ... most commonly diagnosed health problems in cats, yet relatively little ... now. Two collaborative studies have been conducted by researchers from ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
Breaking Biology Technology:
(Date:10/29/2015)... 2015 NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... a leading marketplace to discover and buy innovative ... wallet on StackSocial for this holiday season.   ... "Company"), a biometric authentication company focused on the ...
(Date:10/27/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... has adopted the Synaptics ® ClearPad ® ... its newest flagship smartphones, the Nexus 5X by LG ... --> --> Synaptics works closely ... collaboration in the joint development of next generation technologies. ...
(Date:10/23/2015)... 23, 2015 Research and Markets ( ... Voice Recognition Biometrics Market 2015-2019" report to their ... The global voice recognition biometrics market to grow ... --> --> The report, ... based on an in-depth market analysis with inputs from ...
Breaking Biology News(10 mins):